ProShare Advisors’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

ProShare Advisors’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-63,212	Closed	-$10.9M	–	1919
2015 Q1	$10.9M	Buy	63,212 +7,629	+14%	+$1.12M	0.13%	170
2014 Q4	$6.39M	Sell	55,583 -11,832	-18%	-$1.43M	0.07%	279
2014 Q3	$10.5M	Sell	67,415 -2,010	-3%	-$291K	0.14%	135
2014 Q2	$8.56M	Buy	69,425 +12,495	+22%	+$1.38M	0.11%	170
2014 Q1	$5.9M	Sell	56,930 -17,672	-24%	-$1.81M	0.07%	245
2013 Q4	$6.71M	Buy	74,602 +45,833	+159%	+$3.66M	0.1%	200
2013 Q3	$1.92M	Buy	28,769 +13,541	+89%	+$933K	0.05%	424
2013 Q2	$1.01M	Buy	+15,228	New	+$871K	0.02%	852

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

ProShare Advisors's SLXP Position: Q2 2015 in Review

ProShare Advisors sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 63,212 shares — an estimated $10.9M sold.

ProShare Advisors first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $10.9M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

ProShare Advisors reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
ProShare Advisors sold 63,212 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $10.9M.
ProShare Advisors first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
ProShare Advisors's SALIX PHARMACEUTICALS LTD DEL position peaked at $10.9M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on ProShare Advisors's 13F filing for Q2 2015, filed 11 Aug 2015.